See more : Peer to Peer Network (PTOP) Income Statement Analysis – Financial Results
Complete financial analysis of ThermoGenesis Holdings, Inc. (THMO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ThermoGenesis Holdings, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- PRISMX GLOBAL VENTURES LIMITED (PRISMX.BO) Income Statement Analysis – Financial Results
- Blue Moon Group Holdings Limited (BLUMY) Income Statement Analysis – Financial Results
- Lifestyle International Holdings Limited (LFSYY) Income Statement Analysis – Financial Results
- Pingdingshan Tianan Coal. Mining Co., Ltd. (601666.SS) Income Statement Analysis – Financial Results
- Crown LNG Holdings Limited (CGBS) Income Statement Analysis – Financial Results
ThermoGenesis Holdings, Inc. (THMO)
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.45M | 10.48M | 9.29M | 9.74M | 13.05M | 9.67M | 12.03M | 14.53M | 11.93M | 16.04M | 15.99M | 17.96M | 19.02M | 23.40M | 23.09M | 19.80M | 21.95M | 16.75M | 12.05M | 10.18M | 11.65M | 10.19M | 9.55M | 5.79M | 4.21M | 5.10M | 4.50M | 6.60M | 4.10M | 3.30M | 2.70M | 2.00M | 1.80M | 1.80M | 1.10M | 1.20M | 500.00K | 100.00K |
| Cost of Revenue | 7.51M | 7.77M | 5.80M | 8.49M | 7.35M | 7.48M | 7.72M | 8.69M | 9.19M | 11.29M | 10.10M | 11.60M | 12.69M | 14.56M | 15.64M | 14.11M | 14.98M | 11.55M | 7.71M | 7.09M | 7.84M | 7.90M | 7.56M | 5.01M | 4.25M | 3.70M | 5.00M | 4.00M | 1.60M | 1.90M | 1.40M | 1.00M | 1.20M | 600.00K | 400.00K | 500.00K | 100.00K | 0.00 |
| Gross Profit | 1.93M | 2.71M | 3.49M | 1.26M | 5.70M | 2.19M | 4.31M | 5.84M | 2.74M | 4.75M | 5.89M | 6.37M | 6.33M | 8.84M | 7.45M | 5.69M | 6.97M | 5.20M | 4.34M | 3.09M | 3.80M | 2.29M | 1.99M | 780.00K | -35.00K | 1.40M | -500.00K | 2.60M | 2.50M | 1.40M | 1.30M | 1.00M | 600.00K | 1.20M | 700.00K | 700.00K | 400.00K | 100.00K |
| Gross Profit Ratio | 20.44% | 25.85% | 37.58% | 12.92% | 43.66% | 22.67% | 35.84% | 40.20% | 23.00% | 29.60% | 36.82% | 35.43% | 33.29% | 37.76% | 32.25% | 28.75% | 31.76% | 31.03% | 36.05% | 30.34% | 32.65% | 22.45% | 20.85% | 13.47% | -0.83% | 27.45% | -11.11% | 39.39% | 60.98% | 42.42% | 48.15% | 50.00% | 33.33% | 66.67% | 63.64% | 58.33% | 80.00% | 100.00% |
| Research & Development | 1.28M | 1.66M | 2.21M | 2.48M | 2.40M | 3.01M | 4.49M | 2.50M | 3.23M | 5.94M | 3.47M | 2.99M | 3.73M | 3.00M | 5.01M | 5.22M | 7.17M | 4.11M | 4.16M | 5.67M | 3.47M | 2.94M | 2.28M | 1.78M | 1.62M | 2.00M | 3.90M | 3.60M | 1.30M | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 5.73M | 6.38M | 8.29M | 7.92M | 10.87M | 8.23M | 10.70M | 8.49M | 5.65M | 5.22M | 5.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 1.95M | 1.66M | 1.36M | 1.69M | 1.53M | 2.15M | 2.97M | 2.97M | 2.96M | 2.76M | 3.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.22M | 7.24M | 8.52M | 7.68M | 8.03M | 9.65M | 9.01M | 12.40M | 10.38M | 13.67M | 11.46M | 8.60M | 7.98M | 8.67M | 7.69M | 9.25M | 10.17M | 9.63M | 7.16M | 5.84M | 5.17M | 5.01M | 4.84M | 3.89M | 4.20M | 4.80M | 4.60M | 3.50M | 1.60M | 1.10M | 1.80M | 1.30M | 1.90M | 1.30M | 1.10M | 1.00M | 1.30M | 600.00K |
| Other Expenses | 0.00 | -3.00K | 802.00K | -8.00K | -33.00K | -24.00K | 0.00 | 180.00K | -44.00K | 21.00K | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.54M | 8.90M | 10.72M | 10.15M | 10.43M | 12.66M | 13.51M | 14.90M | 13.61M | 19.61M | 14.93M | 11.59M | 11.71M | 11.67M | 12.70M | 14.47M | 17.34M | 13.74M | 11.31M | 11.51M | 8.65M | 7.95M | 7.13M | 5.67M | 5.82M | 7.40M | 9.00M | 7.40M | 3.10M | 1.70M | 1.90M | 1.50M | 2.10M | 1.60M | 1.30M | 1.10M | 1.40M | 700.00K |
| Cost & Expenses | 18.33M | 16.68M | 16.53M | 18.64M | 17.78M | 20.14M | 21.22M | 23.58M | 22.79M | 30.90M | 25.03M | 23.19M | 24.40M | 26.24M | 28.34M | 28.58M | 32.31M | 25.29M | 19.02M | 18.60M | 16.49M | 15.85M | 14.68M | 10.68M | 10.07M | 11.10M | 14.00M | 11.40M | 4.70M | 3.60M | 3.30M | 2.50M | 3.30M | 2.20M | 1.70M | 1.60M | 1.50M | 700.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.19M | 1.77M | 828.00K | 216.00K | 90.00K | 0.00 | 110.00K | 130.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 10.03M | 5.62M | 6.10M | 7.91M | 4.48M | 2.70M | 0.00 | 20.52M | 7.99M | 14.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00K | 23.00K | 0.00 | 13.00K | 1.11M | 0.00 | 0.00 | 0.00 | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | 100.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.15M | 926.00K | 633.00K | 754.00K | 806.00K | 670.00K | 644.00K | 830.00K | 1.17M | 1.35M | 993.00K | 538.00K | 604.00K | 466.00K | 492.00K | 474.00K | 543.00K | 549.00K | 118.00K | 367.00K | 302.00K | 266.00K | 434.00K | 485.00K | 677.00K | 600.00K | 500.00K | 300.00K | 200.00K | 200.00K | 100.00K | 200.00K | 200.00K | 300.00K | 200.00K | 100.00K | 100.00K | 100.00K |
| EBITDA | -7.74M | -5.27M | -6.60M | -8.16M | -4.73M | -42.30M | -8.55M | -8.42M | -9.70M | -13.49M | -8.05M | -4.69M | -4.78M | -2.37M | -4.76M | -8.30M | -9.82M | -7.99M | -6.85M | -8.06M | -4.54M | -5.40M | -4.70M | -4.41M | -5.18M | -5.40M | -9.00M | -4.50M | -400.00K | -100.00K | -500.00K | -300.00K | -1.30M | -100.00K | -400.00K | -300.00K | -900.00K | -500.00K |
| EBITDA Ratio | -81.95% | -50.27% | -62.36% | -83.75% | -30.47% | -101.51% | -71.11% | -55.41% | -81.66% | -84.07% | -50.33% | -38.13% | -25.10% | -10.12% | -20.63% | -41.94% | -44.76% | -47.71% | -56.87% | -79.15% | -39.00% | -52.99% | -49.23% | -76.07% | -122.94% | -105.88% | -200.00% | -68.18% | -9.76% | -12.12% | -18.52% | -15.00% | -72.22% | -5.56% | -36.36% | -33.33% | -200.00% | -600.00% |
| Operating Income | -8.61M | -6.19M | -7.23M | -8.90M | -4.73M | -43.55M | -9.20M | -9.37M | -10.87M | -14.86M | -9.04M | -3.07M | -5.38M | -2.84M | -5.25M | -8.78M | -10.37M | -8.54M | -6.97M | -8.42M | -4.84M | -5.66M | -5.14M | -4.89M | -5.85M | -6.00M | -9.50M | -4.80M | -600.00K | -300.00K | -600.00K | -500.00K | -1.50M | -400.00K | -600.00K | -400.00K | -1.00M | -600.00K |
| Operating Income Ratio | -91.16% | -59.08% | -77.80% | -91.29% | -36.28% | -450.22% | -76.47% | -64.50% | -91.08% | -92.63% | -56.55% | -17.06% | -28.28% | -12.12% | -22.76% | -44.34% | -47.24% | -50.99% | -57.85% | -82.76% | -41.59% | -55.60% | -53.78% | -84.44% | -139.02% | -117.65% | -211.11% | -72.73% | -14.63% | -9.09% | -22.22% | -25.00% | -83.33% | -22.22% | -54.55% | -33.33% | -200.00% | -600.00% |
| Total Other Income/Expenses | -10.31M | -5.62M | -4.65M | -7.92M | -5.37M | -2.13M | -1.00M | -20.53M | -7.72M | 7.00K | 6.00K | -21.00K | 393.00K | 268.00K | 61.00K | 228.00K | 1.19M | 1.77M | 0.00 | 202.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 300.00K | 600.00K | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K |
| Income Before Tax | -18.92M | -11.81M | -11.88M | -16.81M | -10.10M | -45.67M | -10.02M | -29.77M | -18.59M | -14.85M | -9.03M | -3.09M | -4.99M | -2.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -300.00K | -900.00K | -500.00K |
| Income Before Tax Ratio | -200.31% | -112.68% | -127.82% | -172.53% | -77.40% | -472.19% | -83.29% | -204.94% | -155.82% | -92.58% | -56.51% | -17.18% | -26.21% | -10.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -25.00% | -180.00% | -500.00% |
| Income Tax Expense | 0.00 | 5.07M | 6.40M | 7.44M | 3.83M | -4.73M | -4.48M | -673.00K | 7.95M | 35.00K | -403.00K | -2.14M | 0.00 | 0.00 | -61.00K | -228.00K | -1.19M | -1.77M | -828.00K | -202.00K | -67.00K | -61.00K | -97.00K | 1.84M | -36.00K | 100.00K | 100.00K | 0.00 | 0.00 | -200.00K | 0.00 | -200.00K | 0.00 | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K |
| Net Income | -17.98M | -11.27M | -11.38M | -16.35M | -9.50M | -39.72M | -4.57M | -29.10M | -18.59M | -14.85M | -8.63M | -3.09M | -4.99M | -2.57M | -5.19M | -8.55M | -9.18M | -6.78M | -6.14M | -8.22M | -4.78M | -5.60M | -5.04M | -6.73M | -5.82M | -6.10M | -9.60M | -4.80M | -600.00K | -100.00K | 0.00 | -300.00K | -1.50M | -700.00K | -800.00K | -500.00K | -1.10M | -800.00K |
| Net Income Ratio | -190.31% | -107.51% | -122.43% | -167.81% | -72.79% | -410.63% | -37.97% | -200.31% | -155.82% | -92.58% | -53.99% | -17.18% | -26.21% | -10.97% | -22.49% | -43.18% | -41.83% | -40.45% | -50.98% | -80.77% | -41.02% | -55.00% | -52.76% | -116.25% | -138.16% | -119.61% | -213.33% | -72.73% | -14.63% | -3.03% | 0.00% | -15.00% | -83.33% | -38.89% | -72.73% | -41.67% | -220.00% | -800.00% |
| EPS | -7.59 | -20.45 | -43.41 | -117.20 | -151.09 | -971.34 | -203.28 | -1.32K | -2.78K | -3.31K | -3.21K | -1.68K | -2.74K | -1.56K | -3.33K | -5.49K | -5.93K | -4.42K | -4.46K | -6.52K | -4.12K | -5.51K | -5.15K | -7.63K | -8.44K | -10.66K | -18.29K | -10.91K | -1.70K | -283.29 | 0.00 | -1.17K | -6.07K | -3.20K | -4.65K | -3.73K | -8.27K | -6.67K |
| EPS Diluted | -7.59 | -20.45 | -43.41 | -117.20 | -151.09 | -971.34 | -203.28 | -1.32K | -2.78K | -3.31K | -3.21K | -1.68K | -2.74K | -1.56K | -3.33K | -5.49K | -5.93K | -4.42K | -4.46K | -6.52K | -4.12K | -5.51K | -5.15K | -7.63K | -8.44K | -10.66K | -18.29K | -10.91K | -1.70K | -283.29 | 0.00 | -1.17K | -6.07K | -3.20K | -4.65K | -3.73K | -8.27K | -6.67K |
| Weighted Avg Shares Out | 2.37M | 550.99K | 262.13K | 139.51K | 62.86K | 40.89K | 22.46K | 22.04K | 6.69K | 4.48K | 2.69K | 1.84K | 1.82K | 1.65K | 1.56K | 1.56K | 1.55K | 1.53K | 1.38K | 1.26K | 1.16K | 1.02K | 978.00 | 883.00 | 689.00 | 572.00 | 525.00 | 440.00 | 353.00 | 353.00 | 282.00 | 257.00 | 247.00 | 219.00 | 172.00 | 134.00 | 133.00 | 120.00 |
| Weighted Avg Shares Out (Dil) | 2.37M | 550.99K | 262.13K | 139.51K | 62.86K | 40.89K | 22.46K | 22.04K | 6.69K | 4.48K | 2.69K | 1.84K | 1.82K | 1.65K | 1.56K | 1.56K | 1.55K | 1.53K | 1.38K | 1.26K | 1.16K | 1.02K | 978.00 | 883.00 | 689.00 | 572.00 | 525.00 | 440.00 | 353.00 | 353.00 | 282.00 | 257.00 | 247.00 | 219.00 | 172.00 | 134.00 | 133.00 | 120.00 |
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
ThermoGenesis (NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants...
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced...
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D.
Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript
Thermogenesis Holdings, Inc. (NASDAQ:THMO ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - CFO Conference Call Participants Sean Lee - H.C....
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
RANCHO CORDOVA, Calif. , July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the appointments of Biao Xi, Ph.D.
Source: https://incomestatements.info
Category: Stock Reports